FDA’s Good Review Management Practices To Debut In “Near Future”
This article was originally published in The Pink Sheet Daily
Executive Summary
Even as the agency wrestles with the transformation brought by FDAAA, shifts in how it processes NDAs may be the "most important," CDER official says.